DK442886A - Peptider med vaekst- og/eller laktationsfremmende virkning, fremgangsmaade til fremstilling heraf samt syntetisk dna til brug ved fremgangsmaaden - Google Patents

Peptider med vaekst- og/eller laktationsfremmende virkning, fremgangsmaade til fremstilling heraf samt syntetisk dna til brug ved fremgangsmaaden Download PDF

Info

Publication number
DK442886A
DK442886A DK442886A DK442886A DK442886A DK 442886 A DK442886 A DK 442886A DK 442886 A DK442886 A DK 442886A DK 442886 A DK442886 A DK 442886A DK 442886 A DK442886 A DK 442886A
Authority
DK
Denmark
Prior art keywords
procedure
lactating
peptides
growth
producing
Prior art date
Application number
DK442886A
Other languages
Danish (da)
English (en)
Other versions
DK442886D0 (da
Inventor
Brent Robert Larsen
Ned Roger Siegel
Claire Elaine Kotts
Michael Francis Mcgrath
Sharon Diane Ogden
John Casey Minnerly
Gwen Grabowski Krivi
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of DK442886D0 publication Critical patent/DK442886D0/da
Publication of DK442886A publication Critical patent/DK442886A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK442886A 1985-09-17 1986-09-16 Peptider med vaekst- og/eller laktationsfremmende virkning, fremgangsmaade til fremstilling heraf samt syntetisk dna til brug ved fremgangsmaaden DK442886A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77711785A 1985-09-17 1985-09-17
US06/888,996 US4783524A (en) 1985-09-17 1986-07-31 Growth factors

Publications (2)

Publication Number Publication Date
DK442886D0 DK442886D0 (da) 1986-09-16
DK442886A true DK442886A (da) 1987-05-27

Family

ID=27119279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK442886A DK442886A (da) 1985-09-17 1986-09-16 Peptider med vaekst- og/eller laktationsfremmende virkning, fremgangsmaade til fremstilling heraf samt syntetisk dna til brug ved fremgangsmaaden

Country Status (9)

Country Link
US (1) US4783524A (fr)
EP (1) EP0216742A3 (fr)
AU (1) AU601374B2 (fr)
DK (1) DK442886A (fr)
GR (1) GR862367B (fr)
HU (1) HU202582B (fr)
IL (1) IL80043A0 (fr)
NZ (1) NZ217596A (fr)
PL (1) PL154336B1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
US5019559A (en) * 1986-11-14 1991-05-28 President And Fellows Of Harvard College Wound healing using PDGF and IGF-II
US5218093A (en) * 1989-03-01 1993-06-08 Allelix Biopharmaceuticals, Inc. EGF variants and pharmaceutical use thereof
US5093317A (en) * 1989-06-05 1992-03-03 Cephalon, Inc. Treating disorders by application of insulin-like growth factor
US6693076B1 (en) 1989-06-05 2004-02-17 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US5652214A (en) * 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US6723699B1 (en) 1989-06-05 2004-04-20 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
EP0544706A4 (en) * 1990-06-29 1993-10-13 Hoffmann-La Roche Inc. Histidine substituted growth hormone releasing factor analogs
US6319522B1 (en) 1990-07-13 2001-11-20 Gropep Limited Growth-promoting agent
DK0545946T3 (da) * 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
US7033610B2 (en) * 1990-07-13 2006-04-25 Gropep Pty, Ltd. Growth-promoting agent
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
EP0490249B1 (fr) * 1990-12-10 1995-03-15 F. Hoffmann-La Roche Ag Procédé de préparation enzymatique de GRF(1-44)NH2
CA2084061A1 (fr) * 1991-04-09 1992-10-10 Arthur M. Felix Analogues du facteur liberant l'hormone de croissance
SE9101840L (sv) * 1991-06-14 1992-12-15 Kabi Pharmacia Ny medicinsk anvaendning
US6310040B1 (en) 1991-11-08 2001-10-30 Cephalon, Inc. Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
EP0779927A1 (fr) * 1994-09-08 1997-06-25 Chiron Corporation Procede de production amelioree des facteurs de croissance proches de l'insuline
US5728676A (en) * 1994-09-08 1998-03-17 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
US20070004641A1 (en) * 2001-05-24 2007-01-04 Neuren Pharmaceuticals Limited Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate
US7605177B2 (en) * 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
EP1401808B1 (fr) 2001-05-24 2009-07-08 Neuren Pharmaceuticals Limited Peptidomimetiques et analogues de gpe
US7714020B2 (en) * 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
GB0313892D0 (en) * 2003-06-16 2003-07-23 Hannah Res Inst Control of lactation
WO2014205617A1 (fr) * 2013-06-24 2014-12-31 Shandong University Peptide marqué au lanthanide et utilisation de celui-ci

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207842A (en) * 1983-04-25 1988-02-12 Chiron Corp Production of human insulin-like growth factor (igf) using cdna
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes

Also Published As

Publication number Publication date
HUT43626A (en) 1987-11-30
IL80043A0 (en) 1986-12-31
PL261419A1 (en) 1987-07-27
DK442886D0 (da) 1986-09-16
AU6271286A (en) 1987-03-19
GR862367B (en) 1987-03-24
EP0216742A3 (fr) 1989-11-15
PL154336B1 (en) 1991-08-30
HU202582B (en) 1991-03-28
NZ217596A (en) 1991-06-25
US4783524A (en) 1988-11-08
EP0216742A2 (fr) 1987-04-01
AU601374B2 (en) 1990-09-13

Similar Documents

Publication Publication Date Title
DK442886D0 (da) Peptider med vaekst- og/eller laktationsfremmende virkning, fremgangsmaade til fremstilling heraf samt syntetisk dna til brug ved fremgangsmaaden
DK80291D0 (da) 1,3,9,9a-tetrahydro-imidazooe4,5-baaquinolin-2-oner samt fremgangsmaade til fremstilling deraf
DK162099C (da) Antibiotika, fremgangsmaade til fremstilling deraf samt mikroorganismer til anvendelse ved fremgangsmaaden
IL91500A0 (en) Protein of paramyxovirus,method for the production thereof and vaccine containing the same
FI873570A7 (fi) Peptidivalmiste, menetelmä sen valmistamiseksi ja sen käyttö.
DK110885A (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
EP0188388A3 (en) Alpha-alumina particles, and process for preparing the same
DK542387A (da) Uvaevede stoffer samt fremgangsmaade til fremstilling deraf
IL81839A0 (en) Polypeptide,dna and its use
DE3677904D1 (de) Aufzeichnungsfluessigkeit und aufzeichnungsverfahren unter verwendung derselben.
FI861398A7 (fi) Analog branddetektor samt brandalarmsystem utnyttjande densamma.
KR910001049A (ko) 메틸요구 효모 알콜 산화효소 ⅱ 조절 영역을 암호화하는 dna 서열 및 그의 제조방법
EP0429544A4 (en) Synthetic, anti-complement protein and the gene encoding same
FI882554A7 (fi) Kahvalla varustettu lohkonmuotoinen kassi ja menetelmä kassin valmistamiseksi.
DK654987D0 (da) Antibiotisk komplex benaevnt a10255 og dettes faktorer samt fremgangsmaade til fremstilling heraf og mikroorganismer til brug ved fremgangsmaaden
DE3674116D1 (de) Behaelter, insbesondere zur aufnahme von lebensmitteln.
DK18086D0 (da) Vaeksthormon-frigoerende peptider samt midler med indhold heraf
DK533186A (da) Haette til perkutan indretning samt fremgangsmaade til brug af haetten
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
DK579786A (da) Imidazopyridazinalkensyreamider, deres fremstilling og anvendelse samt mellemprodukter til brug ved fremstillingen
NO861356L (no) Overflatefartoey med slingrekjoeler.
DE3682358D1 (de) Expressionsvektoren zur verwendung in e. coli.
NO863619D0 (no) Epoksy-novolak-harpikser, samt fremgangsmaate for fremstilling av slike.
NO860753L (no) Hydroksypropylmetylcelluloseeter, samt fremgangsmaate for dens fremstilling.
DE68912536D1 (de) Flüssiges Nahrungsmittel zur Proteinzuführung.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment